Bellevue Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Bellevue Group’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-91,916	Closed	-$1.21M	–	150
2025 Q1	$1.21M	Sell	91,916 -5,984	-6%	-$82.6K	0.03%	105
2024 Q4	$1.55M	Sell	97,900 -5,075	-5%	-$76.2K	0.03%	110
2024 Q3	$1.64M	Sell	102,975 -13,665	-12%	-$220K	0.03%	109
2024 Q2	$1.78M	Sell	116,640 -87,840	-43%	-$1.26M	0.03%	112
2024 Q1	$3M	Sell	204,480 -100,020	-33%	-$1.46M	0.05%	104
2023 Q4	$4.24M	Sell	304,500 -96,500	-24%	-$1.29M	0.06%	98
2023 Q3	$5.41M	Sell	401,000 -57,500	-13%	-$778K	0.09%	100
2023 Q2	$5.79M	Sell	458,500 -59,000	-11%	-$689K	0.08%	101
2023 Q1	$5.89M	Sell	517,500 -110,000	-18%	-$1.19M	0.09%	100
2022 Q4	$6.43M	Buy	627,500 +565,500	+912%	+$6.1M	0.09%	105
2022 Q3	$664K	Hold	62,000	–	–	0.01%	143
2022 Q2	$687K	Buy	62,000 +19,500	+46%	+$212K	0.01%	143
2022 Q1	$474K	Hold	42,500	–	–	0.01%	157
2021 Q4	$556K	Hold	42,500	–	–	0.01%	160
2021 Q3	$554K	Hold	42,500	–	–	0.01%	162
2021 Q2	$625K	Hold	42,500	–	–	0.01%	153
2021 Q1	$522K	Hold	42,500	–	–	0.01%	157
2020 Q4	$606K	Hold	42,500	–	–	0.01%	163
2020 Q3	$591K	Sell	42,500 -142,500	-77%	-$1.7M	0.01%	163
2020 Q2	$1.96M	Buy	+185,000	New	+$1.88M	0.03%	136

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bellevue Group's RDY Position: Q2 2025 in Review

Bellevue Group sold out of Dr. Reddy's Laboratories (RDY) in Q2 2025, closing a stake of 91,916 shares — an estimated $1.21M sold.

Bellevue Group first reported a position in RDY in Q2 2020 and held it in 20 quarters. The position peaked at $6.43M in Q4 2022. 243 funds tracked by Wall St. Rank hold RDY as of Q2 2025.

Bellevue Group reported no remaining Dr. Reddy's Laboratories position as of Q2 2025 after selling out during the quarter.
Bellevue Group sold 91,916 Dr. Reddy's Laboratories shares in Q2 2025, an estimated $1.21M.
Bellevue Group first reported a position in Dr. Reddy's Laboratories in Q2 2020 and held it in 20 quarters.
Bellevue Group's Dr. Reddy's Laboratories position peaked at $6.43M in Q4 2022.
243 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2025.

Based on Bellevue Group's 13F filing for Q2 2025, filed 14 Aug 2025.